Synopsis: In a case with implications for the litigious molecular diagnostics space and written description law, Chief Judge Connolly ...

This review discusses the current state of multicancer early detection tests, the role of machine learning in their ...

CareDx continues its growth trajectory with solid margins and EBITDA. Find out why CDNA stock offers a promising outlook ...

Discover how circulating cell-free DNA (cfDNA) is transforming the diagnosis and monitoring of metabolic diseases like ...

The Global Synthetic Biology Market is estimated to be valued at USD 13.83 billion in 2023 and is projected to expand at a robust Compound Annual Growth Rate (CAGR) of 17.30% over the forecast period ...

Chemical and biomolecular engineers at Georgia Tech have created a plug-and-play platform for the detection of disease protein biomarkers that is straightforward, adaptable, and user-friendly, ...

Natera, Inc. , a global leader in cell-free DNA and genetic testing, today announced the enrollment of the first patients in the HEROES clinical trial. HEROES is a multi-center, phase II trial that ...

Discover the price reduction of ENFINIA™ DNA products by 25%, improving access to high-quality DNA for researchers.

Chemical and biomolecular engineers at Georgia Tech have developed a plug-and-play platform that's simple, flexible, and easy ...

Elegen, a leader in next-generation cell-free DNA manufacturing, today announced a 25% reduction in price for ENFINIAtm DNA, making industry-leading long, complex, NGS-verified DNA more accessible to ...

Price drop reflects efficiency gains from Co.’s cell-free cloning tech & new facility, where automation & ML have increased ...

DNA sequencing can uncover the complex genetic and epigenetic factors that cause aggressive paediatric cancers and their ...